Creative Medical Technology Holdings, Inc.
Clinical trials sponsored by Creative Medical Technology Holdings, Inc., explained in plain language.
Biotech company focused on regenerative medicine and stem cell therapies.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New injection could ease chronic back pain without surgery Results expected Jan 2027 (estimated)
- Could a single cell infusion help newly diagnosed type 1 diabetes patients? Results expected Jan 2027 (estimated)